A Retrospective Comparison of Ceftriaxone Versus Oxacillin for Osteoarticular Infections Due to Methicillin-Susceptible Staphylococcus aureus | Zendy

Bruce W. Wieland | Zendy; Jodie R. Marcantoni | Zendy; Kerry M. Bommarito | Zendy; David K. Warren | Zendy; Jonas Marschall | Zendy

Open Access

A Retrospective Comparison of Ceftriaxone Versus Oxacillin for Osteoarticular Infections Due to Methicillin-Susceptible Staphylococcus aureus

Author(s) -

Bruce W. Wieland,

Jodie R. Marcantoni,

Kerry M. Bommarito,

David K. Warren,

Jonas Marschall

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir857

Subject(s) - ceftriaxone , medicine , antibiotics , staphylococcus aureus , cephalosporin , retrospective cohort study , antibacterial agent , surgery , microbiology and biotechnology , genetics , bacteria , biology

Antistaphylococcal penicillins are the treatment of choice for methicillin-susceptible Staphylococcus aureus (MSSA) infection. Ceftriaxone can be dosed once daily and is less expensive for outpatient therapy than oxacillin. We compared patient outcomes of MSSA osteoarticular infections treated with ceftriaxone versus oxacillin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research